AR104502A1 - Procedimiento para la preparación de 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-l-alanil-l-alaninato-monohidrocloruro - Google Patents

Procedimiento para la preparación de 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-l-alanil-l-alaninato-monohidrocloruro

Info

Publication number
AR104502A1
AR104502A1 ARP160101245A ARP160101245A AR104502A1 AR 104502 A1 AR104502 A1 AR 104502A1 AR P160101245 A ARP160101245 A AR P160101245A AR P160101245 A ARP160101245 A AR P160101245A AR 104502 A1 AR104502 A1 AR 104502A1
Authority
AR
Argentina
Prior art keywords
chlorophenyl
methyl
monohidrocloruro
dician
alaninato
Prior art date
Application number
ARP160101245A
Other languages
English (en)
Inventor
Becker Guido
Keil Birgit
Dr Olenik Britta
Dr Heilmann Werner
Dr Mais Franz-Josef
Original Assignee
Bayer Pharma Aktiegesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma Aktiegesellschaft filed Critical Bayer Pharma Aktiegesellschaft
Publication of AR104502A1 publication Critical patent/AR104502A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicación 1: 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-L-alanil-L-alaninato-monohidrocloruro de la fórmula (1) en forma cristalina de la modificación I caracterizado porque el difractograma de rayos X del compuesto muestra un pico máximo del ángulo 2q en 6.5, 8.7 y 24.3.
ARP160101245A 2015-05-06 2016-05-02 Procedimiento para la preparación de 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-l-alanil-l-alaninato-monohidrocloruro AR104502A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15166606 2015-05-06

Publications (1)

Publication Number Publication Date
AR104502A1 true AR104502A1 (es) 2017-07-26

Family

ID=53283983

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101245A AR104502A1 (es) 2015-05-06 2016-05-02 Procedimiento para la preparación de 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-l-alanil-l-alaninato-monohidrocloruro

Country Status (1)

Country Link
AR (1) AR104502A1 (es)

Similar Documents

Publication Publication Date Title
EP3578137A4 (en) TOOL FOR TRICUSPIDAL REGURGITATION OPERATION
LT3395818T (lt) 2-(morfolin-4-il)-1,7-naftiridinai
PE20201444A1 (es) Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido
CY1121988T1 (el) Θεραπευτικη αγωγη της πολλαπλης σκληρυνσης
AR095435A1 (es) Formas salinas del (2-(2-(4-fluorofenil)tiazol-4-il)propan-2-il)carbamato de (s)-quinuclidin-3-ilo
PH12019500252A1 (en) Compound for use in the treatment of neurogenic orthostatic hypotension
PL3105009T3 (pl) Przenośna obrabiarka do drewna do obróbki obszaru krawędziowego płyty meblowej z drewna
ZA202107474B (en) Sulcardine salts
EP3187185A4 (en) Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound
PH12017502010A1 (en) Process for the preparation of 2-{4-[2-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl]phenoxy}ethyl-l-alanyl-l-alaninate monohydrochloride
PH12021550456A1 (en) Crystalline forms of a quinazole compound and its hydrochloride salts
EP3541801A4 (en) 4- (6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
AR104502A1 (es) Procedimiento para la preparación de 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-l-alanil-l-alaninato-monohidrocloruro
EP3541797A4 (en) 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
EP3606524A4 (en) (S) -2- (4- (PIPERIDIN-3-YL) PHENYL) -2H-INDAZOLE-7-CARBOXAMIDE DEUTERATED
IL272835A (en) Salts of a compound and crystalline forms thereof
USD804559S1 (en) Camera
MX2020009412A (es) Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido.
EP3630750A4 (en) SALTS AND CRYSTALLINE FORMS OF A COMPOUND
PL3898612T3 (pl) Podstawione pirydynyloksybenzeny, ich sole oraz zastosowanie jako aktywne składniki herbicydowe
SMP201600404B1 (it) Dispositivo per regolare l'angolazione di un disco di macchine per il dissodamento del terreno
PT3395818T (pt) 2-(morfolin-4-il)-1,7-naftiridinas
TH1601003377A (th) สารประกอบ (6S,9aS)-N-เบนซิล-6-[(4-ไฮดรอกซีฟีนิล)เมทิล]-4,7-ไดออกโซ-8-({6-[3-(พิเพอราซิน-1-อิล)อะเซทิดิน-1-อิล]ไพริดิน-2-อิล}เมทิล)-2-(พรอพ-2-เอน-1-อิล)-ออคตะไฮโดร-1H-ไพราซิโน[2,1-c][1,2,4]ไตรอะซีน-1-คาร์บอกซาไมด์
HUP1600436A2 (en) Salts for the preparation of a pharmaceutical composition
UA32787S (uk) Кавовий столик «арахіс»

Legal Events

Date Code Title Description
FB Suspension of granting procedure